Prosecution Insights
Last updated: November 04, 2026

Glucolight Medical Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Glucolight Medical Inc. is active in the Medical Devices & Mechanical Engineering technology area, where it currently faces 1 pending office action. This action is under the review of 1 distinct examiner, suggesting a streamlined approach to its current patent filings. The company's work is situated within 1 distinct art unit, which provides a stable regulatory framework for its intellectual property development.

The busiest examiner, OGLES, MATTHEW ERIC, is managing the 1 busiest examiner pending action for the company. Since there is only 1 distinct examiner, the company's prosecution strategy is entirely focused on meeting the specific expectations of this individual. This concentration simplifies the management of the portfolio, as there are no other examiners or art units to coordinate with at this time.

With 1 pending office action, the company's current engagement with the USPTO is limited in scale. The Medical Devices & Mechanical Engineering sector can be broad, but the use of 1 distinct art unit indicates a specific technical niche. Practitioners can dedicate their resources to addressing the concerns raised in the 1 pending office action, knowing that OGLES, MATTHEW ERIC is the sole arbiter for this current stage of prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
OGLES, MATTHEW ERIC 1 50.0% +58.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17216677 Glucose Annunciator And Method Of Operation Thereof OGLES, MATTHEW ERIC —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17216677 Glucose Annunciator And Method Of Operation Thereof OGLES, MATTHEW ERIC —

Top Art Units

Art UnitApps
3791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17216677 Glucose Annunciator And Method Of Operation Thereof OGLES, MATTHEW ERIC 3791 §103§112 Final Rejection — Pending Mar 30, 2021

Managing Glucolight Medical Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Glucolight Medical Inc. have?

Glucolight Medical Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Glucolight Medical Inc. applications?

Matthew Eric Ogles has the most, with 1 of Glucolight Medical Inc.'s pending office actions.

What technology area are Glucolight Medical Inc.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month